Pentostatin clinical trials
Also written Nipent and Deoxycoformycin.
How each study uses Pentostatin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Pentostatin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 11 Oct 1991 · NIPENT · NDA 020122 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2005 (7)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2000 | 4 |
| 2002 | 3 |
| 2003 | 5 |
| 2004 | 2 |
| 2005 | 7 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 40
M.D. Anderson Cancer Center (4) · Mayo Clinic (4) · National Cancer Institute (NCI) (3) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Eastern Cooperative Oncology Group (3) · Memorial Sloan Kettering Cancer Center (3) · University of Nebraska (2) · Ohio State University Comprehensive Cancer Center (2)
Often tested with
Tested in the same studies.
Cyclophosphamide (19) · Rituximab (14) · Alemtuzumab (6) · Mycophenolic Acid (4) · Methotrexate (4) · Ofatumumab (3) · Bendamustine (2) · Sirolimus (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Pentostatin.
Studies
Open first, then newest update. How each study uses Pentostatin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 44
- A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic AnemiaRecruitingPhase 1City of Hope Medical CenterNCT05757310Written as PentostatinHow we know
- Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell LeukemiaActive, not recruitingPhase 2National Cancer Institute (NCI)NCT01059786Written as PentostatinHow we know
- Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant FailureActive, not recruitingPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT02105766Written as PentostatinHow we know
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell DiseaseActive, not recruitingPhase 1/2National Heart, Lung, and Blood Institute (NHLBI)NCT03077542Written as PentostatinHow we know
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationActive, not recruitingPhase 2National Cancer Institute (NCI)NCT03663933Written as PentostatinHow we know
- Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and LymphomaTerminatedPhase 1Sidney Kimmel Cancer Center at Thomas Jefferson UniversityNCT01352312Written as PentostatinHow we know
- Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHDTerminatedPhase 1/2Astex Pharmaceuticals, Inc.NCT00032773Written as pentostatin for injectionHow we know
- Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell TransplantCompletedPhase 2University of NebraskaNCT00571662Written as PentostatinHow we know
- Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerWithdrawnPhase 1/2University of NebraskaNCT00816413Written as pentostatinHow we know
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLLCompletedPhase 2Eastern Cooperative Oncology GroupNCT00074282Written as pentostatinHow we know
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedPhase 2Eastern Cooperative Oncology GroupNCT00045305Written as PentostatinHow we know
- Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedPhase 2Eastern Cooperative Oncology GroupNCT00057954Written as PentostatinHow we know
- Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanCompletedPhase 2M.D. Anderson Cancer CenterNCT00496873Written as NipentHow we know
- Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host DiseaseCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00074035Written as pentostatinHow we know
- Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)CompletedPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT00224874Written as PentostatinHow we know
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell TransplantCompletedPhase 2Fred Hutchinson Cancer CenterNCT00096161Written as PentostatinHow we know
- Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedPhase 2Mayo ClinicNCT00602836Written as PentostatinHow we know
- SS1P and Pentostatin Plus Cyclophosphamide for MesotheliomaCompletedPhase 1/2National Cancer Institute (NCI)NCT01362790Written as PentostatinHow we know
- A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid MalignanciesCompletedPhase 2M.D. Anderson Cancer CenterNCT00038025Written as Deoxycoformycin (DCF)How we know
- Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedPhase 2Mayo ClinicNCT01024010Written as PentostatinHow we know
See all 44 studies that test Pentostatin →
Given beside what is tested · 4 — Pentostatin is usual care or a partner of the new treatment
- A Blood Stem Cell Transplant for Sickle Cell DiseaseActive, not recruitingPhase 1City of Hope Medical CenterNCT03249831Written as PentostatinHow we know
- DCF Combined With Camrelizumab in the Treatment of Esophageal CancerStatus unknownNot applicableXijing HospitalNCT05050760Written as DCFHow we know
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney CancerCompletedPhase 2National Cancer Institute (NCI)NCT00923845Written as PentostatinHow we know
- A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of MalignanciesCompletedPhase 2Yale UniversityNCT00402714Written as PentostatinHow we know
As the comparator · 1 — what is tested is compared with Pentostatin
Codes
What other systems call Pentostatin · ClinicalTrials.gg INT008479
- MeSH (NLM) D015649PentostatinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 395575MZO7PENTOSTATINConfirmed FDA, NLM, Wikidata
- RxNorm 8011Confirmed FDA, Wikidata
- Wikidata Q425470pentostatinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C732PentostatinOne source FDA
- DrugBank DB00552One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015649 | Pentostatin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 395575MZO7 | PENTOSTATIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8011 | — | Confirmed FDA, Wikidata |
| Wikidata | Q425470 | pentostatin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C732 | Pentostatin | One source FDA |
| DrugBank | DB00552 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.